<DOC>
	<DOCNO>NCT01358799</DOCNO>
	<brief_summary>The objective multi-center clinical study demonstrate APTIMA ( R ) Assay Chlamydia trachomatis ( CT ; `` ACT Assay '' ) , clear use TIGRIS DTS ( Direct Transfer ) System ( `` TIGRIS System '' ) , test PANTHER System . The intend use ACT Assay unchanged except inclusion use PANTHER System . ACT Assay performance PANTHER System comparable performance TIGRIS System .</brief_summary>
	<brief_title>Clinical Evaluation APTIMA® Assay Chlamydia Trachomatis Using PANTHER™ System</brief_title>
	<detailed_description>This protocol withdraw clinical trials.gov sample collect protocol test per protocol use Gen-Probe APTIMA ( R ) CT ( Chlamydia trachomatis ) Assay . Instead , test conduct result generate Gen-Probe APTIMA ( R ) Combo 2 Assay ( Chlamydia trachomatis Neisseria gonorrhoeae ) . See Protocol Identification AC2PS-US11-001 ( NCT01733069 ) result . This action recommend RRS team per email 8 February 2013 .</detailed_description>
	<mesh_term>Chlamydia Infections</mesh_term>
	<criteria>The subject least 14 year age time inform consent sexually active The subject report symptoms consistent suspected STD abnormal discharge , genital itching , pain/discomfort sexual intercourse urination , and/or low abdominal discomfort . If subject asymptomatic , subject know partner , contact , person confirm suspect STD ( ) , undergo screen evaluation possible STD ( ) , and/or schedule routine exam may include pelvic exam The subject and/or legally authorize representative willing undergo inform consent process prior study participation ( minor need document consent his/her parent legal guardian , unless site IRBapproved waiver parental consent minor ) A potential subject ineligible clinical trial enrollment subject , clinician , medical record report follow : The subject take antibiotic medication within last 21 day The subject underage ( define IRB state law ) , without document consent her/his parent legal guardian ( exception : site IRBapproved waiver parental consent minor ) The subject determine investigator medically unsuitable participation study ( eg , medical history concurrent illness could result unacceptable risk subject ) Concurrent participation clinical study ( y ) may acceptable , approval investigator sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Chlamydia trachomatis</keyword>
	<keyword>APTIMA Assay Chlamydia trachomatis</keyword>
</DOC>